Multikinase Inhibition as a Therapeutic Strategy for Status Epilepticus: Current Evidence and Future Directions
In silico and in vivo investigations indicate that lenvatinib may disrupt neuroinflammatory and vascular alterations essential to SE pathogenesis, and this review seeks to establish a thorough basis for subsequent research on the repurposing of lenvatinib in neurotherapeutics.